Filing Details
- Accession Number:
- 0001225208-19-013933
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-30 12:30:12
- Reporting Period:
- 2019-10-29
- Accepted Time:
- 2019-10-30 12:30:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1446989 | B. Scott Ullem | One Edwards Way Irvine CA 92614 | Cvp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-10-25 | 3,626 | $0.00 | 9,938 | No | 5 | G | Direct | |
Common Stock | Acquisiton | 2019-10-29 | 7,500 | $41.94 | 17,438 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-10-29 | 7,500 | $235.30 | 9,938 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-10-25 | 3,626 | $0.00 | 71,588 | No | 5 | G | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 5 | G | Indirect | By Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Acquire) | Disposition | 2019-10-29 | 7,500 | $0.00 | 7,500 | $41.94 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
58,100 | 2015-05-08 | 2021-05-07 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 26, 2019.